Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors
Primary Purpose
Melanoma (Skin)
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Microsoft Band 2 + UV messaging
Microsoft Band 2
Sponsored by
About this trial
This is an interventional prevention trial for Melanoma (Skin) focused on measuring cancer prevention, sunburn
Eligibility Criteria
Inclusion Criteria:
- 18-75 years old
- Diagnosed with stage I-III cutaneous invasive melanoma between 2009 and 2017 and treated at the University of Minnesota
- Able to read/write in English
- Own a smartphone
- Able to provide voluntary informed consent
Exclusion Criteria:
-Patients currently undergoing adjuvant therapy.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Intervention
Control
Arm Description
Microsoft Band 2 application with UV messaging activated
Microsoft Band 2 application (UV messaging not active)
Outcomes
Primary Outcome Measures
Sunburn
Self-report of a sunburn during study period
Secondary Outcome Measures
Full Information
NCT ID
NCT03518229
First Posted
April 25, 2018
Last Updated
April 15, 2019
Sponsor
University of Minnesota
Collaborators
Melanoma Research Alliance
1. Study Identification
Unique Protocol Identification Number
NCT03518229
Brief Title
Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors
Official Title
Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Withdrawn
Why Stopped
Converted from a pilot into a larger study which we will enter as a new protocol
Study Start Date
February 2020 (Anticipated)
Primary Completion Date
September 2020 (Anticipated)
Study Completion Date
May 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota
Collaborators
Melanoma Research Alliance
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project will pilot test whether a wearable device that tracks sun exposure and provides alerts regarding sun exposure and protection behaviors will reduce sunburns in melanoma survivors. The use of wearable technology devices has grown quickly over the last decade and studies using these devices to promote physical activity and weight loss have been promising. The investigators will pilot test the technology device versus a similar control device in 80 melanoma survivors and compare sunburns between the two groups after the three month intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Melanoma (Skin)
Keywords
cancer prevention, sunburn
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Microsoft Band 2 application with UV messaging activated
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Microsoft Band 2 application (UV messaging not active)
Intervention Type
Device
Intervention Name(s)
Microsoft Band 2 + UV messaging
Intervention Description
wearable device (wrist) and associated mobile application; UV sensor and messaging activated
Intervention Type
Device
Intervention Name(s)
Microsoft Band 2
Intervention Description
wearable device (wrist) and associated mobile application; UV messaging not activated
Primary Outcome Measure Information:
Title
Sunburn
Description
Self-report of a sunburn during study period
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18-75 years old
Diagnosed with stage I-III cutaneous invasive melanoma between 2009 and 2017 and treated at the University of Minnesota
Able to read/write in English
Own a smartphone
Able to provide voluntary informed consent
Exclusion Criteria:
-Patients currently undergoing adjuvant therapy.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors
We'll reach out to this number within 24 hrs